Retraction: Salari et al. Diabetol Metab Syndr _#####################_
10.1186/s13098-021-00733-5
The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding the reliability of the reported data, which the authors addressed by a Correction [1]. However, further issues were subsequently identified with the authors potentially reporting mean differences as standardized mean differences. Post-publication peer review has concluded that the authors’ methodology contains technical and statistical errors, which undermine the conclusions of the article.
Authors Kamran Mansouri and Masoud Mohammadi disagree with this retraction. The other authors have not responded to correspondence regarding this retraction.
Footnotes
The online version of the original article can be found at 10.1186/s13098-021-00733-5
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Salari, N., Jafari, S., Darvishi, N. et al. Correction to: The best drug supplement for obesity treatment: a systematic review and network meta-analysis. Diabetol Metab Syndr 14, 68 (2022). 10.1186/s13098-022-00838-5 [DOI] [PMC free article] [PubMed]